TokenPost topic
1 TokenPost story is tagged PharmaCyte Biotech. The newest appear first.
The split is intended to help the company meet Nasdaq's minimum bid price requirement for continued listing. Split-adjusted trading is scheduled to begin Nov. 13.
Nov 12, 2026, 12:20 AM EST ยท Business
